People exposed to PFAS chemicals tend to have lower levels of total thyroid hormone in their blood and higher levels of the free form, which can disrupt normal metabolism and increase the risk of thyroid dysfunction.
Claim Context
PFAS exposure is associated with disruption of thyroid hormone homeostasis, including reduced serum total thyroxine (T4) levels and increased free T4 concentrations, mediated by competitive binding to transthyretin and inhibition of iodide uptake, suggesting a mechanism for hypothyroidism risk in exposed populations.
“Several studies have found a negative correlation between exposure to PFAS and serum total T4 levels, which could potentially induce hypothyroidism. PFAS competes with T4 for binding to TTR, which may lead to decreased thyroid hormone levels and adverse endocrine-disrupting effects.”
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A meta-analysis of longitudinal studies could quantify the pooled change in TSH and T4 levels per unit increase in serum PFAS concentration in adults and pregnant women.
A systematic review and meta-analysis of 15+ prospective studies measuring serum PFOA, PFOS, and PFHxS at baseline and serial thyroid function tests (TSH, total T4, free T4) over 2–5 years in adults and pregnant women, adjusting for iodine status, age, sex, and thyroid autoantibodies.
An RCT could determine whether reducing PFAS exposure leads to normalization of thyroid hormone levels in individuals with elevated exposure.
A double-blind RCT of 200 adults with serum PFAS >10 ng/mL and subclinical hypothyroidism (TSH 5–10 mIU/L), randomized to receive certified PFAS-removing water filters (intervention) or standard filters (control) for 12 months, with primary outcome being change in serum total T4 and TSH.
A prospective cohort could establish whether baseline PFAS levels predict future development of hypothyroidism or thyroid autoimmunity.
A prospective cohort of 5,000 adults aged 30–65 from PFAS-contaminated regions, with baseline serum PFAS and thyroid antibodies measured, and annual thyroid function tests over 10 years, with adjudication of clinical hypothyroidism by endocrinologists.
A case-control study could compare PFAS levels in individuals with diagnosed hypothyroidism versus euthyroid controls, adjusting for confounders.
A matched case-control study of 400 individuals with newly diagnosed hypothyroidism (TSH >10 mIU/L) and 400 euthyroid controls, matched for age, sex, BMI, and iodine intake, with archived serum PFAS measured from samples collected 1–3 years prior to diagnosis.
A cross-sectional study could identify whether individuals with higher PFAS levels at a single time point also have altered thyroid hormone profiles.
A national cross-sectional survey of 4,000 adults with simultaneous measurement of serum PFAS (PFOA, PFOS, PFHxS) and thyroid function (TSH, total T4, free T4), stratified by water source and dietary iodine intake.